Filing Details

Accession Number:
0001209191-24-003923
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-23 20:03:10
Reporting Period:
2024-02-21
Accepted Time:
2024-02-23 20:03:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Medical Laboratories (8071) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263312 A Jacob Orville C/O Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
General Manager, Screening No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-21 2,034 $0.00 10,692 No 4 A Direct
Common Stock Disposition 2024-02-22 1,013 $59.78 9,679 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,117 Indirect Held in 401(k) Plan
Footnotes
  1. Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024.
  2. Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
  3. In addition to the shares of Common Stock reported on this Form 4, which total 10,796 shares, Mr. Orville also holds, in the aggregate, an additional 39,591 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.